Dreavent 5 II, LP — Form D/A
Dreavent 5 II, LP of Cambridge, MA, a pooled investment fund, filed a Form D amendment with the SEC on 2022-10-27. The offering totals $1.8M, of which $1.8M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-10-27
- Form: D/A
- Accession: 0001946396-22-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $1.8M
- Amount sold: $1.8M
- Minimum investment: $100K
- Investors: 19
- Date of first sale: 2022-09-08
- Security types: fund interests
- SEC file number: 021-458535
Issuer
- Name: Dreavent 5 II, LP
- CIK: 0001941648
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 1 Broadway, Cambridge, MA, 02142
- Phone: 16176858854
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Richard Thoms | Executive Officer | Salt Lake City, UT |
| LLC Assure Fund Management II | Executive Officer | Salt Lake City, UT |
| Gorka Fius | Executive Officer | Cambridge, MA |
| Null Dreavent Inc | Director | Cambridge, MA |
Other filings by this issuer (3)
More